Subtitle
Lung treatment with pencil beam scanner at the Texas Center of Proton Therapy
Subtitle
Lung treatment with pencil beam scanner at the Texas Center of Proton Therapy
Case Time
2017
Please connect to access this resource and get a more personalized Campus experience
No account yet? Request access
Executive summary
Body
The Texas Center for Proton Therapy brings an advanced cancer treatment to North Texas that offers more hope to cancer patients. The 63,000-square-foot center can treat more than 100 patients per day between three treatment rooms.
The clinical team under the leadership of Andrew K. Lee, M.D., M.P.H., medical director, has developed a comprehensive program to treat patients suffering from lung cancers.
Key content topics
Top cancer treatments
Related contents
Proton Therapy Publication
June 2024
Proton and carbon ion radiotherapy for operable early-stage lung cancer; a prospective nationwide registry.
Proton Therapy Publication
July 2024
A Pilot Trial of Proton Based Cardiac Sparing Accelerated Fractionated RadioTherapy in Unresectable Non-Small Cell Lung Cancer with Extended Durvalumab Therapy (PARTICLE-D).
Proton Therapy Publication
August 2024
Sparing of the heart facilitates recovery from cardiopulmonary side effects after thoracic irradiation.
Proton Therapy Publication
August 2024
Parallel explorations in LA-NSCLC: Chemoradiation dose-response optimisation considering immunotherapy and cardiac toxicity sparing.
Proton Therapy Publication
April 2024
A bibliometric analysis of cardiotoxicity in cancer radiotherapy.
Proton Therapy Publication
March 2024
FLASH radiotherapy for the treatment of symptomatic bone metastases in the thorax (FAST-02): protocol for a prospective study of a novel radiotherapy approach.
Proton Therapy Publication
February 2024
Prospective study investigating hypofractionated proton beam therapy in patients with inoperable early stage non-small cell lung cancer.
Proton Therapy Publication
April 2024
Long-term survival outcomes and quality of life of image-guided proton therapy for operable stage I non-small cell lung cancer: A phase 2 study.
Proton Therapy Publication
January 2024
Proton and photon radiotherapy in stage III NSCLC: Effects on hematological toxicity and adjuvant immune therapy.